Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTopical Therapy for Methicillin-Resistant Staphylococcus aureus Colonization: Impact on Infection Risk
Infection Control and Hospital Epidemiology, 06/08/09
Robicsek A et al. - Mupirocin-based decolonization therapy temporarily reduced the risk of continued colonization but did not decrease the risk of subsequent infection.
Related Articles
Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/21/09
Relevance Score: 83%
Association between Plaque-Type Psoriasis and Perianal Streptococcal Cellulitis and Review of the Literature
Archives of Iranian Medicine, 11/12/09
Relevance Score: 80%
Exit Site Infections: Systematic Microbiologic and Quality Control Are Needed
Advances in Peritoneal Dialysis, 10/21/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients
Expert Opinion in Pharmacotherapy, 12/14/09
Relevance of CD38 Expression on CD8 T Cells to Evaluate Antiretroviral Therapy Response in HIV-1-infected Youths
Scandinavian Journal of Immunology, 12/14/09
Today in Drug Resistance...keeping you current
Receive free subspecialty "5-minute updates" via email
Reduction of blood pressure in patients with treatment-resistant hypertension
Expert Opinion in Pharmacotherapy, 12/09/09
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor